|4Jun 16, 6:36 PM ET

Dion Gisele 4

4 · Cytek Biosciences, Inc. · Filed Jun 16, 2023

Insider Transaction Report

Form 4
Period: 2023-06-14
Dion Gisele
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-14+30,24230,242 total
    Exercise: $8.38From: 2024-06-14Exp: 2033-06-14Common Stock (30,242 underlying)

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION